Konstantina Bitchava

Dr. Konstantina Bitchava

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
ITIosif Tammas
Iosif Tammas
KBKonstantina Bitchava
Konstantina Bitchava
Athanasios GelasakisAthanasios Gelasakis
Athanasios Gelasakis
Aquaculture has rapidly emerged as one of the fastest growing industries, expanding both on global and on national fronts. With the ever-increasing demand for proteins with a high biological value, the aquaculture industry has established itself as one of the most efficient forms of animal production, proving to be a vital component of global food production by supplying nearly half of aquatic food products intended for human consumption. As in classic animal production, the prevention of diseases constitutes an enduring challenge associated with severe economic and environmental repercussions. Nevertheless, remarkable strides in the development of aquaculture vaccines have been recently witnessed, offering sustainable solutions to persistent health-related issues challenging resilient aquaculture production. These advancements are characterized by breakthroughs in increased species-specific precision, improved vaccine-delivery systems, and innovations in vaccine development, following the recent advent of nanotechnology, biotechnology, and artificial intelligence in the -omics era. The objective of this paper was to assess recent developments and milestones revolving around aquaculture vaccinology and provide an updated overview of strengths, weaknesses, opportunities, and threats of the sector, by incorporating and comparatively discussing various diffuse advances that span across a wide range of topics, including emerging vaccine technologies, innovative delivery methods, insights on novel adjuvants, and parasite vaccine development for the aquaculture sector.

26 April 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
ALAthanasios Lattos
Athanasios Lattos
KBKonstantina Bitchava
Konstantina Bitchava
Ioannis A GiantsisIoannis A Giantsis
Ioannis A Giantsis
JTJohn A. Theodorou
John A. Theodorou
Costas BatargiasCostas Batargias
Costas Batargias
BMBasile Michaelidis
Basile Michaelidis
Pinna nobilis populations, constituting the largest bivalve mollusk endemic to the Mediterranean, is characterized as critically endangered, threatened by extinction. Among the various factors proposed as etiological agents are the Haplosporidium pinnae and Mycobacterium sp. parasites. Nevertheless, devastation of the fan mussel populations is still far from clear. The current work is undertaken under a broader study aiming to evaluate the health status of Pinna nobilis population in Aegean Sea, after the mass mortalities that occurred in 2019. A significant objective was also (a) the investigation of the etiological agents of small-scale winter mortalities in the remaining populations after the devastating results of Haplosporidium pinnae and Mycobacterium sp. infections, as well as (b) the examination of the susceptibility of the identified bacterial strains in antibiotics for future laboratory experiments. Microbiological assays were used in order to detect the presence of potential bacterial pathogens in moribund animals in combination with molecular tools for their identification. Our results provide evidence that Vibrio bacterial species are directly implicated in the winter mortalities, particularly in cases where the haplosporidian parasite was absent. Additionally, this is the first report of Vibrio mediterranei and V. splendidus hosted by any bivalve on the Greek coastline.

28 November 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
Iosif TammasIosif Tammas
Iosif Tammas
KBKonstantina Bitchava
Konstantina Bitchava
Athanasios GelasakisAthanasios Gelasakis
Athanasios Gelasakis
Vaccine adjuvants are crucial for reinforcing the immunogenicity of vaccines. Therefore, they are widely used in the aquaculture sector as vaccine components, facilitating the efficient prevention of infectious diseases and promoting sustainable teleost fish growth. Despite their benefits, there has been a growing concern about the potential adverse effects of vaccine adjuvants in teleost fish, connoting a valid impact on their overall health and welfare. Among the adjuvants used in aquaculture vaccinology, nanoparticle-based formulations have given rise to a promising new alternative to traditional options, such as oil-based emulsions and aluminum compounds, offering the benefit of minimizing relevant side effects. The aim of this paper was to review the current status of the adjuvants used in aquaculture, provide a description and an evaluation of their mode of action and side effects, and explore the potential use of nanoparticle formulations as adjuvants to improve the efficacy of aquaculture vaccines. By demonstrating and assessing the equilibrium between teleost fish welfare and immunological efficacy, this review presents a collective perspective that will assist in establishing a framework for the utilization of effective species-specific practices around adjuvant use in aquaculture, while also addressing the challenges of welfare-friendly immunization.

21 October 2019 in Journal of Fish Diseases
Verified
Journal Article
Closed access
PDF file
KBKonstantina Bitchava
Konstantina Bitchava
TCTaxiarchis Chassalevris
Taxiarchis Chassalevris
ELEirini Lampou
Eirini Lampou
FAFotini Athanassopoulou
Fotini Athanassopoulou
Vangelis  EconomouVangelis Economou
Vangelis Economou
CDChrysostomos I. Dovas
Chrysostomos I. Dovas

17 May 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
NSNadia Stoppani
Nadia Stoppani
Silvia ColussiSilvia Colussi
Silvia Colussi
Paolo PastorinoPaolo Pastorino
Paolo Pastorino
Marino PrearoMarino Prearo
Marino Prearo
SSSimona Sciuto
Simona Sciuto
JFJose Francisco Fernández-Garayzábal
Jose Francisco Fernández-Garayzábal
Lactococcus garvieae is the etiological agent of lactococcosis, a clinically and economically significant infectious disease affecting farmed rainbow trout. L. garvieae had been considered the only cause of lactococcosis for a long time; however, L. petauri, another species of the genus Lactococcus, has lately been linked to the same disease. The genomes and biochemical profiles of L. petauri and L. garvieae have a high degree of similarity. Traditional diagnostic tests currently available cannot distinguish between these two species. The aim of this study was to use the transcribed spacer (ITS) region between 16S rRNA and 23S rRNA as a potential useful molecular target to differentiate L. garvieae from L. petauri, saving time and money compared to genomics methods currently used as diagnostic tools for accurate discrimination between these two species. The ITS region of 82 strains was amplified and sequenced. The amplified fragments varied in size from 500 to 550 bp. Based on the sequence, seven SNPs were identified that separate L. garvieae from L. petauri. The 16S-23S rRNA ITS region has enough resolution to distinguish between closely related L. garvieae and L. petauri and it can be used as a diagnostic marker to quickly identify the pathogens in a lactococcosis outbreak.

10 September 2025 in Animals
Verified
Journal Article
Open access
PDF file
MKMarkos Kolygas
Markos Kolygas
KBKonstantina Bitchava
Konstantina Bitchava
Cosmas NathanailidesCosmas Nathanailides
Cosmas Nathanailides
FAFOTINI ATHANASOPOULOU
FOTINI ATHANASOPOULOU
This review explores the potential of essential oils (EOs) as natural feed additives in aquaculture, highlighting their antimicrobial, antioxidant, and immunostimulatory properties, which contribute to disease prevention and improved fish resilience. EOs, derived from aromatic plants, offer a sustainable alternative to synthetic chemicals, promoting benefits such as enhanced growth rates, feed efficiency, immune function, and reduced pathogen susceptibility. However, several challenges must be addressed to fully unravel their potential, including the optimization of dosages, effective delivery methods, and cost-efficiency. Techniques such as microencapsulation are emerging as promising solutions to improve EO stability and controlled release in aquatic feeds, though further research is needed to refine these approaches and evaluate their scalability. Additionally, there is a need for more research into the mechanisms through which EOs influence fish health, the interactions between active compounds, potential synergistic effects of EO mixtures, and their impact on the aquatic environment and microbiome. Addressing these challenges will ensure the effective and sustainable application of EOs in aquaculture, reducing reliance on synthetic chemicals while fostering a more resilient and eco-friendly industry. A key feature of this review is the systematic presentation of detailed, species-specific tables summarizing the current literature on the application of EOs and plant extracts in fish health management.